|
Login
Directory:
Add Company
| Your company can benefit
from enhanced listings. Questions? Read our FAQ
first. |
Personalized notification service and newsletter info
| Subscribe (free) to get notified
of new additions. |
Learn more About us and about our Services
Contact us
|
Ranitidine 
|
|
75-150-300 mg Effervescent Tablets. Readily available Recent EU registration dossier
Offer available for: licensing Pharmaceutical form and dosage: 75-150-300 mg (effervescent tablets) Tablets
Type:
- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)
Therapeutic target:
- Gastrointestinal
Action: Anti-ulcerants - H2 antagonists (Gastro) |
|
|
Full Description:
Ranitidine effervescent tablets dossier:
-New readily available for licensing
-Stability: 25°C: 24 months + continued, 40°C: 6 months
Availability and Market information:
Status: Registered (MA obtained)
: 2001
Registration info: On request: registration in other countries
Market information
Other Market Info:
Patent Information:
Name: Zantac = Ranic
Patent info: Expired
|
Suggestion box |
Disclaimer | Privacy
Policy | Rules & Regulations
Copyright© Cofidei, Inc. Page Last modified: 15-Jan-2002.
|
Add
Company
Subscribe
Search
Contact
